The Pediatric Neuro-Oncology (PNO) Program at Johns Hopkins is part of the Division of Pediatric Oncology within the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. National Cancer Institute designation as a Comprehensive Cancer Center is the gold standard for cancer hospitals, and Johns Hopkins is the only one that has earned this designation in Maryland. Care for children and young adults with brain and spinal cord tumors is coordinated through a multidisciplinary team of providers who focus their basic, translational and clinical research exclusively on pediatric brain tumors. Pediatric Oncology is located in the new $1.3 billion, 12-story Charlotte R. Bloomberg Children’s Center building, one of the most technologically advanced and comprehensive children’s hospitals in the world. The pediatric oncology unit has separate but adjacent inpatient and outpatient units designed to provide seamless continuity of care for all patients.
Advances have been built on the discoveries of Johns Hopkins scientists including deciphering the genome of more cancer types than any other research team in the world and doing much of the preclinical and translational work for the development of immune-oncology and epigenetic therapies. These discoveries have been used to revolutionize pediatric cancer care through targeted and individualized diagnostics and therapeutics. These kinds of scientific advances define Johns Hopkins, but the facilities that allow us to deliver this care in a welcoming and family friendly environment also make us unique.
Visit the Johns Hopkins Hospital website for more information on housing.
Kenneth J. Cohen, MD, MBA
Principal Investigator, Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology
Eric H. Raabe, MD, PhD
Co-Principal Investigator, Assistant Professor of Oncology
1800 Orleans St., Bloomberg 11379
Baltimore, MD 21287